Impact of aging on long-term cardiac outcomes of true-lumen recanalized chronic total occlusions in patients with overweight/obesity.

Autor: Cheng JF; Cardiovascular Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lee CL; Cardiovascular Division, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan., Chiang JY; Cardiovascular Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Liu SC; Cardiovascular Division, Department of Internal Medicine, Fu Jen Catholic University Hospital, New Taipei City, Taiwan., Huang CH; Cardiovascular Division, Department of Internal Medicine, Cathay General Hospital, Taipei, Taiwan., Liou JT; Cardiovascular Division, Department of Internal Medicine, China Medical University Hsinchu Hospital, Hsinchu, Taiwan., Chang CJ; Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan., Tsai CT; Cardiovascular Division, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan., Tsai CT; Cardiovascular Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Wang YC; Cardiovascular Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. med011@seed.net.tw., Hwang JJ; Cardiovascular Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Cardiovascular Division, Department of Internal Medicine, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.
Jazyk: angličtina
Zdroj: International journal of obesity (2005) [Int J Obes (Lond)] 2024 Dec; Vol. 48 (12), pp. 1767-1774. Date of Electronic Publication: 2024 Sep 04.
DOI: 10.1038/s41366-024-01623-2
Abstrakt: Background: Obesity paradox addressing all-cause mortality has been described in several chronic total occlusion (CTO) studies. However, the impact of aging on long-term cardiac events in patients with overweight and obesity with CTO recanalization were less studied.
Methods: A total of 458 patients (64.4 ± 11.3 years, 403 male) with CTO interventions were enrolled. The overweight/obesity group included 311 patients with body mass index (BMI) ≧24 kg/m 2 and the non-obesity group included 147. With a median follow-up of 40.0 (17.9-61.4) months, 422 patients with successful true-lumen recanalization were further assessed for target lesion failure [TLF: cardiac death, target vessel myocardial infarction (TVMI), target lesion revascularization (TLR)].
Results: At follow-up, the rates of cardiac death, TVMI, TLR, TLF, and stent thrombosis were 1.9%, 1.9%, 9.2%, 10.7%, and 0.5%, respectively. The TVMI-free survival was borderline better (p = 0.067 by log-rank test) in overweight/obesity than non-obesity group. Among patients <65 years of age, the TVMI-free survival was significantly better in the overweight/obesity group (p = 0.013 compared to non-obesity group by log-rank test). In multivariate Cox regression model, the non-obesity patients younger than 65 years were at a higher risk of TVMI, not only among those <65 years of age (hazard ratio = 11.0, 95% CI = 1.1-106.0) but also among the whole patients (hazard ratio=6.9, 95% CI = 1.4-35.1) with successful CTO recanalization.
Conclusions: For those with true-lumen recanalized CTO, the higher risk of TVMI after successful recanalization was rather evident in patients <65 years of age and without overweight/obesity, suggesting that aging might attenuate prognostic significance of "obesity paradox" for CTO interventions.
Competing Interests: Competing interests: The authors declare no competing interests.
(© 2024. The Author(s).)
Databáze: MEDLINE